Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 1/2020

14.12.2018 | Original Research

Surgery for Locally Advanced GIT Cancers Has Potentially Good Postoperative Outcomes in a Tertiary Hospital

verfasst von: Anwar Tawfik Amin, Ahmed A. S. Salem, Abeer Ibrahim

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Adhesions and infiltration into adjacent tissues are present in about 12% of gastrointestinal (GIT) cancers. These adhesions have high potential risk of malignancy. Free resection margin is a predictor of good survival in such patients. This study aims at evaluating the post-operative outcomes after multi-visceral resection of locally advanced gastrointestinal cancers.

Patients and Methods

Ninety patients who underwent extended and multi-visceral resection for GIT cancers invading or adhering to adjacent organs have been included.

Results

For gastric cancer, distal gastrectomy was performed for 12% of the cases and total gastrectomy in 20%. For recto-sigmoid cancer, anterior resection was performed in 18% and abdomino-perineal resection in 7%. Partial colectomy was performed for colonic cancer in 43% of the cases. One organ was excised with GIT tumor in 60 cases (67%). The other 30 cases (33%) required excision of more than one organ. Pathological invasion of adjacent organs was confirmed in 42% of cases. Free margins were obtained in 87% of patients. Morbidity rate was 51%. The most frequent complications were wound infection (17%), anastomotic leak (10%), and chest infection (10%). In this study, 19% required surgical re-intervention. Positive margin and positive lymph nodes (LNs) as well as mucoid adenocarcinoma were associated with a higher recurrence rate.

Conclusion

Achieving free resection margins could be a safe and feasible procedure and may offer good prognosis when followed by adjuvant therapy for patients with locally advanced GIT cancer if patients were precisely selected to have procedure done in a high volume center.
Literatur
1.
Zurück zum Zitat Lopez MJ, Monafo VW. Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery. 1993;113:365–72.PubMed Lopez MJ, Monafo VW. Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery. 1993;113:365–72.PubMed
2.
Zurück zum Zitat Sanfilippo NJ, Crane CH, Skibber J, et al. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys. 2001;51(1):176–83.CrossRef Sanfilippo NJ, Crane CH, Skibber J, et al. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys. 2001;51(1):176–83.CrossRef
3.
Zurück zum Zitat Yiu R, Wong SK, Cromwell J, Madoff RD, Rothenberger DA, Garcia Aguilar J. Pelvic wall involvement denotes a poor prognosis in T4 rectal cancer. Dis Colon Rectum. 2001;44(11):1676–81.CrossRef Yiu R, Wong SK, Cromwell J, Madoff RD, Rothenberger DA, Garcia Aguilar J. Pelvic wall involvement denotes a poor prognosis in T4 rectal cancer. Dis Colon Rectum. 2001;44(11):1676–81.CrossRef
4.
Zurück zum Zitat Talamonti MS, Shumate CR, Carlson GW, Curley SA. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. Surg Gynecol Obstet. 1993;177(5):481–7.PubMed Talamonti MS, Shumate CR, Carlson GW, Curley SA. Locally advanced carcinoma of the colon and rectum involving the urinary bladder. Surg Gynecol Obstet. 1993;177(5):481–7.PubMed
5.
Zurück zum Zitat Bartos A, Bartos D, Dunca F, Mocanu L, Zaharie F, Iancu M, et al. Multi-organ resections for colorectal cancer: analysis of potential factors with role in the occurrence of postoperative complications and deaths. Chir-urgia (Bucur). 2012;107(4):476–82. Bartos A, Bartos D, Dunca F, Mocanu L, Zaharie F, Iancu M, et al. Multi-organ resections for colorectal cancer: analysis of potential factors with role in the occurrence of postoperative complications and deaths. Chir-urgia (Bucur). 2012;107(4):476–82.
8.
Zurück zum Zitat Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235(2):217–25.CrossRef Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002;235(2):217–25.CrossRef
9.
Zurück zum Zitat Beyond TMEC; Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100(8):1009–14.CrossRef Beyond TMEC; Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100(8):1009–14.CrossRef
10.
Zurück zum Zitat Mañas MJ, Espín E, López-Cano M, Vallribera F, Armengol-Carrasco M. Multivisceralresection for locally advanced rectal cancer: prognostic factors influencing outcome. Scand J Surg. 2015;104(3):154–60.CrossRef Mañas MJ, Espín E, López-Cano M, Vallribera F, Armengol-Carrasco M. Multivisceralresection for locally advanced rectal cancer: prognostic factors influencing outcome. Scand J Surg. 2015;104(3):154–60.CrossRef
11.
Zurück zum Zitat Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.CrossRef Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.CrossRef
12.
Zurück zum Zitat Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109–16.CrossRef Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109–16.CrossRef
13.
Zurück zum Zitat Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA. 2000;284:1008–15.CrossRef Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA. 2000;284:1008–15.CrossRef
16.
Zurück zum Zitat Costa SR, Henriques AC, Horta SH, Waisberg J, Speranzini MB. En- bloc pancreatoduodenectomy and right hemicolectomy for treating locally advanced right colon cancer (T4): a series of five patients. Arq Gastroenterol. 2009;46:151–3.CrossRef Costa SR, Henriques AC, Horta SH, Waisberg J, Speranzini MB. En- bloc pancreatoduodenectomy and right hemicolectomy for treating locally advanced right colon cancer (T4): a series of five patients. Arq Gastroenterol. 2009;46:151–3.CrossRef
20.
Zurück zum Zitat Hunter JA, Ryan JA Jr, Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg. 1987;154:67–71.CrossRef Hunter JA, Ryan JA Jr, Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg. 1987;154:67–71.CrossRef
22.
Zurück zum Zitat Kim JH, Jang YJ, Park SS, Park SH, Kim SJ, Mok YJ, et al. Surgical outcomes and prognostic factors for T4 gastric cancers. Asian J Surg. 2009;32:198–204.CrossRef Kim JH, Jang YJ, Park SS, Park SH, Kim SJ, Mok YJ, et al. Surgical outcomes and prognostic factors for T4 gastric cancers. Asian J Surg. 2009;32:198–204.CrossRef
23.
Zurück zum Zitat Persiani R, Antonacci V, Biondi A, Rausei S, La Greca A, et al. Determinants of surgical morbidity in gastric cancer treatment. J Am Coll Surg. 2008;207:13–9.CrossRef Persiani R, Antonacci V, Biondi A, Rausei S, La Greca A, et al. Determinants of surgical morbidity in gastric cancer treatment. J Am Coll Surg. 2008;207:13–9.CrossRef
24.
Zurück zum Zitat Fukuda N, Sugiyama Y, Wada J. Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection. World J Gastroenterol. 2011;17:1180–4.CrossRef Fukuda N, Sugiyama Y, Wada J. Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection. World J Gastroenterol. 2011;17:1180–4.CrossRef
25.
Zurück zum Zitat Mita K, Ito H, Fukumoto M, Murabayashi R, Koizumi K, Hayashi T, et al. Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer. Am J Surg. 2012;203:107–11.CrossRef Mita K, Ito H, Fukumoto M, Murabayashi R, Koizumi K, Hayashi T, et al. Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer. Am J Surg. 2012;203:107–11.CrossRef
26.
Zurück zum Zitat Ozer I, Bostanci EB, Orug T, Ozogul YB, Ulas M, Ercan M, et al. Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer. Am J Surg. 2009;198:25–30.CrossRef Ozer I, Bostanci EB, Orug T, Ozogul YB, Ulas M, Ercan M, et al. Surgical outcomes and survival after multiorgan resection for locally advanced gastric cancer. Am J Surg. 2009;198:25–30.CrossRef
27.
Zurück zum Zitat Oñate Ocaña LF, Becker M, Carrillo JF, Aiello Crocifoglio V, Gallardo Rincón D, et al. Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma. J Surg Oncol. 2008;98:336–42.CrossRef Oñate Ocaña LF, Becker M, Carrillo JF, Aiello Crocifoglio V, Gallardo Rincón D, et al. Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma. J Surg Oncol. 2008;98:336–42.CrossRef
28.
Zurück zum Zitat Aizawa M, Gotohda N, Takahashi S, Konishi M, Kinoshita T. Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer. World J Surg. 2011;35:2717–22.CrossRef Aizawa M, Gotohda N, Takahashi S, Konishi M, Kinoshita T. Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer. World J Surg. 2011;35:2717–22.CrossRef
29.
Zurück zum Zitat Brar SS, Seevaratnam R, Cardoso R, Yohanathan L, Law C, Helyer L, et al. Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer. 2012;15:100–7.CrossRef Brar SS, Seevaratnam R, Cardoso R, Yohanathan L, Law C, Helyer L, et al. Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer. 2012;15:100–7.CrossRef
30.
Zurück zum Zitat Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S. Multivariate prognostic study on large gastric cancer. J Surg Oncol. 2007;96:14–8.CrossRef Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S. Multivariate prognostic study on large gastric cancer. J Surg Oncol. 2007;96:14–8.CrossRef
31.
Zurück zum Zitat Tjandra JJ, Kilkenny JW, Buie WD, Hyman N, Simmang C, Anthony T, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2005;48(3):411–23.CrossRef Tjandra JJ, Kilkenny JW, Buie WD, Hyman N, Simmang C, Anthony T, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2005;48(3):411–23.CrossRef
32.
Zurück zum Zitat Pawlik TM, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol. 2006;13(5):612–62.CrossRef Pawlik TM, Skibber JM, Rodriguez-Bigas MA. Pelvic exenteration for advanced pelvic malignancies. Ann Surg Oncol. 2006;13(5):612–62.CrossRef
33.
Zurück zum Zitat Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Surgical outcomes in patients with T4 gastric carcinoma. J Am Coll Surg. 2006;202:223–30.CrossRef Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Surgical outcomes in patients with T4 gastric carcinoma. J Am Coll Surg. 2006;202:223–30.CrossRef
38.
Zurück zum Zitat Jeong O, Choi WY, Park YK. Appropriate selection of patients for combined organ resection in cases of gastric carcinoma invading adjacent organs. J Surg Oncol. 2009;100:115–20.CrossRef Jeong O, Choi WY, Park YK. Appropriate selection of patients for combined organ resection in cases of gastric carcinoma invading adjacent organs. J Surg Oncol. 2009;100:115–20.CrossRef
39.
Zurück zum Zitat D Amato A, Santella S, Cristaldi M, Gentili V, Pronio A, et al. The role of extended total gastrectomy in advanced gastric cancer. Hepato-Gastroenterology. 2004;51:609–12. D Amato A, Santella S, Cristaldi M, Gentili V, Pronio A, et al. The role of extended total gastrectomy in advanced gastric cancer. Hepato-Gastroenterology. 2004;51:609–12.
41.
Zurück zum Zitat Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol. 2010;28:2430–6.CrossRef Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol. 2010;28:2430–6.CrossRef
Metadaten
Titel
Surgery for Locally Advanced GIT Cancers Has Potentially Good Postoperative Outcomes in a Tertiary Hospital
verfasst von
Anwar Tawfik Amin
Ahmed A. S. Salem
Abeer Ibrahim
Publikationsdatum
14.12.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 1/2020
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0181-5

Weitere Artikel der Ausgabe 1/2020

Journal of Gastrointestinal Cancer 1/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.